Healthcare Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round March 12, 2019 β 11:02
Investment OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio May 31, 2017 β 10:00
